Protalix Biotherapeutics (PLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,604 | -1,100 | -3,455 | -3,619 | 2,932 |
| Depreciation Amortization | 1,465 | 1,078 | 706 | 346 | 1,304 |
| Income taxes - deferred | 340 | 177 | 118 | -113 | 236 |
| Accounts receivable | -5,890 | -11,768 | -6,919 | -2,275 | 2,317 |
| Other Working Capital | -10,119 | -15,875 | -8,739 | -1,840 | 793 |
| Other Operating Activity | 8,815 | 13,465 | 7,998 | 2,443 | 1,092 |
| Operating Cash Flow | $-11,993 | $-14,023 | $-10,291 | $-5,058 | $8,674 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 4,298 | N/A | N/A | N/A | 20,420 |
| PPE Investments | -1,638 | -1,235 | -737 | -306 | -1,279 |
| Purchase Of Investment | -5,000 | N/A | N/A | N/A | -15,000 |
| Other Investing Activity | -26 | -19 | -13 | -6 | 80 |
| Investing Cash Flow | $-2,366 | $-1,254 | $-750 | $-312 | $4,221 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | N/A | -20,420 |
| Common Stock Issued | 9,326 | 9,180 | 9,180 | 5,076 | 3,626 |
| Financing Cash Flow | $9,326 | $9,180 | $9,180 | $5,076 | $-16,794 |
| Exchange Rate Effect | -47 | -16 | -4 | -8 | 25 |
| Beginning Cash Position | 19,760 | 19,760 | 19,760 | 19,760 | 23,634 |
| End Cash Position | 14,680 | 13,647 | 17,895 | 19,458 | 19,760 |
| Net Cash Flow | $-5,080 | $-6,113 | $-1,865 | $-302 | $-3,874 |
| Free Cash Flow | |||||
| Operating Cash Flow | -11,993 | -14,023 | -10,291 | -5,058 | 8,674 |
| Capital Expenditure | -1,638 | -1,235 | -737 | -306 | -1,282 |
| Free Cash Flow | -13,631 | -15,258 | -11,028 | -5,364 | 7,392 |